Abstract
In this review 4 experts consider the major safety concerns relating to bisphosphonate therapy for osteoporosis. Specific topics covered are skeletal safety (particularly with respect to atypical fractures and delayed healing), gastrointestinal intolerance, hypocalcemia, acute-phase (i.e., postdose) reactions, chronic musculoskeletal pain, renal safety, and cardiovascular safety (specifically, atrial fibrillation).
| Original language | English |
|---|---|
| Journal | American Journal of Medicine |
| Volume | 122 |
| Issue number | 2 SUPPL. |
| DOIs | |
| State | Published - 2009 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine(all)
Cite this
Safety of Bisphosphonates in the Treatment of Osteoporosis. / Recker, Robert R.; Lewiecki, E. Michael; Miller, Paul D.; Reiffel, James.
In: American Journal of Medicine, Vol. 122, No. 2 SUPPL., 2009.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Safety of Bisphosphonates in the Treatment of Osteoporosis
AU - Recker, Robert R.
AU - Lewiecki, E. Michael
AU - Miller, Paul D.
AU - Reiffel, James
PY - 2009
Y1 - 2009
N2 - In this review 4 experts consider the major safety concerns relating to bisphosphonate therapy for osteoporosis. Specific topics covered are skeletal safety (particularly with respect to atypical fractures and delayed healing), gastrointestinal intolerance, hypocalcemia, acute-phase (i.e., postdose) reactions, chronic musculoskeletal pain, renal safety, and cardiovascular safety (specifically, atrial fibrillation).
AB - In this review 4 experts consider the major safety concerns relating to bisphosphonate therapy for osteoporosis. Specific topics covered are skeletal safety (particularly with respect to atypical fractures and delayed healing), gastrointestinal intolerance, hypocalcemia, acute-phase (i.e., postdose) reactions, chronic musculoskeletal pain, renal safety, and cardiovascular safety (specifically, atrial fibrillation).
UR - http://www.scopus.com/inward/record.url?scp=58949086108&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58949086108&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2008.12.004
DO - 10.1016/j.amjmed.2008.12.004
M3 - Article
VL - 122
JO - American Journal of Medicine
JF - American Journal of Medicine
SN - 0002-9343
IS - 2 SUPPL.
ER -